Merck | MRK - Sales Revenues


Merck reported EUR5.13B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Adidas EUR 6.74B 150M Jun/2026
Adyen EUR 1.42B 329.01M Dec/2025
Akzo Nobel EUR 2.59B 200M Jun/2026
Alcon AG USD 2.69B 10M Mar/2026
Amadeus IT EUR 1.65B 30M Jun/2026
Amarin USD 49.22M 451K Dec/2025
AstraZeneca USD 15.38B 90M Jun/2026
BASF EUR 17.21B 1.19B Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Beiersdorf EUR 2.45B 30M Jun/2026
Covestro EUR 6.73B 3.82B Jun/2026
Danone EUR 7.22B 510M Jun/2026
Fresenius EUR 5.95B 210M Jun/2026
Fresenius Medical Care EUR 4.86B 250M Jun/2026
Genmab DKK 1.06B 36M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 8.41B 781M Jun/2026
GRIFOLS EUR 1.87B 170M Jun/2026
Henkel EUR 10.35B 255M Jun/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Infineon EUR 4.17B 360M Jun/2026
Lakefront Biotherapeutics EUR 6.5M 894.32M Mar/2026
Linde USD 8.78B 17M Mar/2026
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.13B 120M Mar/2026
Novartis USD 14.41B 1.3B Jun/2026
Philips EUR 4.36B 450M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 11.95B 710M Jun/2026
UCB EUR 4.25B 764M Dec/2025